Both in Pharmaceuticals
Scienture Holdings vs Skye Bioscience
Over the past year SCNX returned −74.9% and SKYE returned −86.0%; their daily moves had a correlation of 0.00.
SCNX −74.9% SKYE −86.0%Growth of $1, one year, split-adjusted
| Metric | SCNX | SKYE |
|---|---|---|
| Price | $3.36 | $1.55 |
| Market cap | $5.5M | $6.9M |
| Today | −0.59% | −2.52% |
| 1 month | −57.1% | −1.3% |
| 6 months | −66.0% | −75.4% |
| Year to date | −73.6% | −74.2% |
| 1 year | −81.2% | −87.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | 97.7% | — |
| Net margin | −821.3% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$1.4M | $9.9M |
| Dividend yield | — | — |
| Volatility (60d) | 932.8% | 616.6% |
| Short % of float | 3.6% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).